Asceneuron
Develops effective therapeutics for orphan tauopathies
Asceneuron has raised €27M across 1 funding round from 1 investor, most recently a Series A round in Sep 2015. Based in Lausanne, Switzerland; founded 2012; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€27M
€27,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2015-09
latest 2015-09
Funding by year
EUR raised per yearAsceneuron — funding by year — interactive chart.
Data table
| Asceneuron — funding by year | |
|---|---|
| 2015 | €27M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-09-01 | Series A | €27M | Sofinnova Partners | View deal → |
Investors
1Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData